Champions Oncology: Falls after Q1 results disappoint

Champions Oncology

16/09/2019 22:22

** Cancer-focused R&D company's shares  CSBR.O  down 16.7%
at $5.75 after market; Set for worst day in nine months if
losses hold
    ** Company reports Q1 adj loss of 5 cents/shr vs adj profit
of 5 cents/shr a year earlier  urn:newsml:reuters.com:*:nACSJHnrja
    ** Analysts had expected company to report profit of 4
cents/shr
    ** Company Reports quarterly revenue of $6.7 mln missing est
of $7.5 mln according to Refinitv IBES estimates
    ** "While our first quarter financial results were slightly
weaker than expected, the cause was mainly due to the timing of
study completions and revenue recognition" - CEO Ronnie Morris 
    ** Stock fell ~12% YTD

 (Reporting by Neha Malara in Bengaluru)
 ((Neha.Malara@thomsonreuters.com; within U.S.+1 646 223 8780;
outside U.S. +91 80 6749 0344;))